Abstract
Purpose
To verify which of the diagnostic modalities: Voiding cystouretrography (VCUG), Sonouretrography (SUG) or Magnetic resonance uretrography (MRU) is the most accurate in the assessment of urethral strictures in males and in what cases the application of novel imaging techniques benefits most.
Methods
55 male patients with a diagnosis of urethral stricture, were enrolled in this prospective study. Initial diagnosis of urethral stricture was based on anamnesis, uroflowmetry and VCUG. Additional imaging procedures—SUG and MRU were performed before the surgery. Virtual models and 3D printed models of the urethra with the stricture were created based on the MRU data. Exact stricture length and location were evaluated by each radiological method and accuracy was verified intraoperatively. Agreement between SUG and MRU assessments of spongiofibrosis was evaluated. MRU images were independently interpreted by two radiologists (MRU 1, MRU 2) and rater reliability was calculated.
Results
MRU was the most accurate [(95% CI 0.786–0.882), p < 0.0005] with an average overestimation of 1.145 mm (MRU 1) and 0.727 mm (MRU 2) as compared with the operative measure. VCUG was less accurate [(95% CI 0.536–0.769), p < 0.0005] with an average underestimation of 1.509 mm as compared with operative measure. SUG was the least accurate method [(95% CI 0.510–0.776), p < 0.0005] with an average overestimation of 2.127 mm as compared with the operative measure. There was almost perfect agreement of MRU interpretations between the radiologists.
Conclusions
VCUG is still considered as a ‘gold standard’ in diagnosing urethral stricture disease despite its limitations. SUG and MRU provide extra guidance in preoperative planning and should be considered as supplemental for diagnosing urethral stricture. Combination of VCUG and SUG may be an optimal set of radiological tools for diagnosing patients with urethral strictures located in the penile urethra. MRU is the most accurate method and should particularly be considered in cases of post-traumatic or multiple strictures and strictures located in the posterior urethra.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Urethral stricture disease significantly impacts the patient’s quality of life. The incidence of urethral stricture (US) related to rapid development and accessibility to minimally invasive, transurethral urological procedures as well as urethral traumas linked to traffic or workplace accidents is increasing. The prevalence of US resulting from inflammation or traumatic catheter insertion seems to be stable [1].
Treatment results are not satisfactory. Medical centers lacking adequate experience often treat patients without sufficient preoperative evaluation, relying solely on anamnesis and uroflowmetry, sometimes complemented by urethroscopy. Due to accessibility, urethral dilatation and Direct Visual Internal Urethrotomy (DVIU) are still repeatedly performed, despite their high failure rates. On the contrary, precise preoperative diagnostics, along with the experience of the surgeon provide excellent outcomes even in complex cases [2].
An objective method of measuring voiding performance—uroflowmetry, supplemented by a subjective questionnaire that quantifies the severity of voiding symptoms—International Prostate Symptom Score (IPSS) remain the primary forms of evaluation of the patient with US. Yet, as recommended by an International Consultation on Urethral Strictures—uroflowmetry and IPSS should remain supplementary to imaging or cystourethroscopy in the initial diagnosis of US. Thus, despite numerous advantages, limited information provided by this routine prompted researchers to look for more accurate solutions [3,4,5].
For over a century, cystouretrography (CUG) and voiding cystouretrography (VCUG) have been the standard imaging procedures depicting location and length of the stricture. Novel methods such as sonouretrography (SUG) and magnetic resonance uretrography (MRU) gained recognition in recent years and are now established diagnostic tools in urethral stricture disease providing data regarding location and extension of the stricture, presence of spongiofibrosis and other periurethral conditions [6]. Additionally, MRU provides high resolution and excellent soft-tissue contrast allowing volumetric presentation of the results as a valuable supplement.
The above-mentioned diagnostic techniques applied preoperatively influence the optimal surgical approach and may often be a key element for successful treatment. Urethroplasty remains the ‘gold standard’ treatment with a high long-term success rate, yet besides adequate experience, requires precise preoperative qualification.
In our opinion, there is a need for complex evaluation of available imaging methods, to improve preoperative planning protocol in individual cases. Thus, the authors of this research, using their own clinical data, attempted to verify which of the diagnostic modalities: CUG/VCUG, SUG or MRU is the most accurate when compared to intraoperative findings, and in which patients an extension of diagnostics is most valuable.
Methods
Study group
Between September 2017 and October 2019, 55 male patients admitted to the Urology Department of our Institution with the diagnosis of urethral stricture disease, were enrolled in this single-center prospective study. The mean age was 57.9 (range 21–82). Diagnosis of US was based on clinical anamnesis, CUG/VCUG or urethroscopy and uroflowmetry performed prior to admission to the hospital or on the day of admission [7]. Medical interview covered information about the previous procedures within the urethra including DVIU, previous dilatations or any surgical treatment. Both newly diagnosed and patients with recurrent US, regardless of its cause or location, were included in the study. To objectively assess the accuracy of the studied imaging methods, each patient included in the study, had all imaging methods performed (CUG/VCUG, SUG and MRU) regardless of the cause and location of the US. In addition to the data on the imaging methods, the authors of this research provide supplementary data including results of uroflowmetry (Qmax) and IPSS—both documented initially and 3–6 months after the surgery to assess the outcomes of the treatment. These data are available as an ‘Appendix’.
The study was approved by the Bioethics Committee in accordance with applicable requirements. Data presenting the location and etiology of the strictures in the studied group are shown in Table 1.
Imaging techniques
CUG/VCUG
Both CUG and VCUG were performed according to a strictly defined scheme as described by McCallum and Colapinto [4]. The penis was placed in the lateral position, with the long axis of the penile urethra perpendicular to the femur. In cases of meatal stenosis or stricture in the penile urethra when introducing the catheter was not possible, a vascular cannula was used for the moment of contrast injection into the urethra. Images of maximum distension of the urethra were taken. In the second phase, VCUG was performed. The bladder was filled to the volume in which the patient reported urgency. Patients in an upright and half-side position were asked to start voiding and a series of images was taken (Fig. 1B, C). Each study was evaluated by a radiologist with over 10 years of experience in uroradiology.
SUG
BK Medical Flex Focus 800 ultrasound unit with a high-frequency linear transducer (18L5) was used. Frequencies varied from 6 to 18 MHz depending on the location of the stricture and amount of fat tissue in the perineal area. The technique of examination was as described by McAnninch et al. [8]. Stricture was detected at the site of urethra that did not comply with the stretching during saline infusion, contrary to a normal urethra that appears as a uniform, echo-free area, 8–10 mm in diameter. Alterations within the corpus spongiosum evaluated as hyperechoic areas compared to the hypoechoic healthy corpus spongiosum were classified as spongiofibrosis (Fig. 1C) [9, 10]. Each study was evaluated by a urologist with over 6 years of experience in urethral ultrasonography and over 200 urethral ultrasound examinations performed prior to this study.
MRU
MRU was performed in a 1.5 Tesla Unit (MagnetomAera, Siemens, Germany) with auto coil selection option with a 20-channel body and spine coil. After sterilization of the penis glans, sterile syringe filled with approximately 10–20 ml of anesthetic gel was introduced into the urethral meatus [11]. Gel was gently infused to distend the urethra. Foley’s catheter balloon was then filled up to 2 ml, and stabilized in fossa navicularis. With the patient in supine position, the penis was placed anteriorly and taped to the abdominal wall, allowing for optimal stretching of the urethra and fixing its position in the axis of midline (Fig. 1A).
Imaging protocol included sagittal T2-weighted Space seq. (TR 1600 TE 95 SL1,0i, FoV 301*301, matrix 288p*320), transverse T2-weighted TSE seq. (TR 5949 TE 97 SL3,0/0,45 FoV 356*356, matrix 359*448) and sagittal T1-weighted VIBE FS seq. (TR 3,4 TE 1,3 SL0.8i, FoV 310*371, matrix 229*352) prior and post i.v. contrast agent administration (delay time 3 and 10 min). Gadolinium contrast agent was used at standard dose of 0.1 mmol/kg of body weight (0.1 ml/kg of body weight) at a rate of 2–3 ml, followed by a 20-ml saline flush.
None of the patients had contraindications to magnetic resonance examination nor administration of contrast agent. Titanium implants/prostheses and previous pelvic orthopedic surgeries are, in most cases, not a contraindication to MRU [12]. Obtained images were independently evaluated by two radiologists (MRU 1, MRU 2) with 7 and 5-year experience in urogenital radiology relatively.
MRU: virtual 3D model segmentation and 3D printing
Images obtained with MRU, were selected and transferred into 3D Slicer, a free open source software for medical image computing. Semi-manual segmentation of the urethra was conducted using the ‘Segment editor’ module. Sagittal T2-weighted Space sequence was used for urethral lumen segmentation and sagittal contrast-enhanced T1-weighted sequence for pathological spongiofibrotic tissue surrounding the strictured part of the urethra. The ‘Model maker’ module was then used to generate 3D virtual models of the urethra with the pathological surrounding tissue marked with a different colour (Fig. 1E). These selections were then exported to the standard tessellation language format (STL), widely used for 3D printing [13]. The Ultimaker3™ 3D-printer was used to create life-size, patient-specific 3D printed models of the urethra with the stricture. To separate the normal urethra from the surrounding pathological tissue as clearly as possible, dual extrusion multi-color printing was used (Fig. 1F).
Radiological findings evaluation
Urethral stricture location, length and the extent of spongiofibrosis were evaluated. Other periurethral pathologies such as diverticula, tumours, fistulae and calcifications were also reported.
The accuracy of US measurement in CUG/VCUG, SUG and MRU was determined in each case in comparison to intraoperative measurement regarded as a reference value [14]. Mainly open surgery procedures—buccal mucosa graft (BMG) urethroplasty and excision with end-to-end urethroplasty—were applied. DVIU was considered and performed only as an initial procedure in short bulbar US.
To compare the agreement between SUG and MRU in the assessment of spongiofibrosis, McAninch and Chiou scales were used [8, 10]. These subjective classifications are routinely used for ultrasonographic evaluation of the degree of urethral damage and indirectly determinate the degree of spongiofibrosis [15]. For the purpose of this study, the authors decided to interpolate both classifications to MRU. CUG/VCUG are not included in this analysis as they do not provide information about spongiofibrosis.
Exact location of the stricture was evaluated by each radiological method and verified intraoperatively (Fig. 1D).
Statistical analysis
Methodology
Urethral stricture length
The accuracy of US length measured by each radiological method (CUG/VCUG, SUG, MRU 1, MRU 2) was compared to the stricture length determined intraoperatively and calculated with weighted Cohen’s κw (as the ratings were non normally distributed).
Moreover, for each of them a deviation from the length determined during the operation was calculated (VCUG dev, SUG dev, MRU 1 dev, MRU 2 dev). Negative numbers indicated an underestimation of the measurement, whereas positive numbers—an overestimation with regards to intraoperative finding—Table 2 and Fig. 2.
To compare the radiological methods directly with each other, for each pair a Wilcoxon signed-rank test was performed to determine the significance of the difference between the measures—Table 3.
In addition, as the MRU is not commonly evaluated by radiologists and might be considered demanding, the authors decided to verify the agreement between investigators. MRU images were independently evaluated by two radiologists (KM-MRU 1, OK-MRU 2). Inter-rater reliability of MRU assessment was calculated with weighted Cohen’s κw (as the ratings were non-normally distributed).
Spongiofibrosis
Spongiofibrosis was assessed based on Chiou [10] and McAninch [8] scales in SUG and adapted for MRU. The agreement between radiological measures (MRU vs SUG), as well as inter-rater reliability (MRU 1 vs MRU 2) was estimated with Cohen’s κw for both of the scales (Table 4). It must be emphasized, that this analysis tests the agreement between the SUG and MRI in the assessment of fibrosis, and not their accuracy. The only indisputable method of accuracy verification would be to perform histopathological evaluation.
Results
Urethral stricture length
Accuracy of radiological methods compared to intraoperative measures are graphically presented on Fig. 2. Based on Landis and Koch [16] statistical methodology the agreement interpretations between radiological and operative measures varied from moderate to almost perfect:
-
MRU was the most accurate [substantial to the almost perfect agreement, κw = 0.834 (95% CI 0.786–0.882), p < 0.0005] with average overestimation of 1.145 mm (MRU 1) and 0.727 mm (MRU 2) as compared with operative measure.
-
CUG/VCUG was less accurate [moderate to a substantial agreement, κw = 0.653 (95% CI 0.536–0.769), p < 0.0005] with average underestimation of 1.509 mm as compared with operative measure.
-
SUG was the least accurate method [κw = 0.643 (95% CI 0.510–0.776], p < 0.0005] with an average overestimation of 2.127 mm as compared with operative measure.
Yet, one must emphasize, that worse accuracy of SUG is a consequence of a few significant outliers in the SUG measurement, all of which were localized in the bulbar urethra. When verified with the Wilcoxon signed-rank test, the CUG/VCUG proved the most different measure (compared with MRU and SUG) with no significant differences between MRU and SUG.
Spongiofibrosis assessment
Agreement between SUG and MRU assessments of spongiofibrosis using the McAnnich and Chiou scales was significant for all included assessments. Its degree varied from moderate to almost perfect—Table 4.
Inter-rater reliability of MRU
There was almost perfect agreement between the radiologists’ assessment (MRU 1 vs MRU 2), κw = 0.883 (95% CI 0.838–0.928), p < 0.0005.
Complications of VCUG, SUG and MRU procedures
The complication that occurred most frequently during imaging methods performed in this research, was local burning pain and discomfort and the site of stricture during the procedure. During VCUG, it was reported by 31 (56.4%) patients, during SUG—22 (40%) patients and 18 (32.7%) patients during MRU. Contrast extravasation was reported in 2 (3.63%) patients during VCUG. No adverse systemic reactions occurred in these patients. No serious bleeding that required intervention was observed in any of the studies. Infections in the postoperative period as a complication of imaging examinations were not reported by the authors, as the short time from examination to surgery prevented a reliable evaluation.
Discussion
Improvement of US treatment results is of the utmost importance in reference to the gradual increase of the number of patients with iatrogenic stenosis. Non-invasive diagnostic methods, such as uroflowmetry and voiding symptom assessment questionnaire—IPSS, despite being highly useful, do not provide enough data for a clear diagnosis, and are, therefore, considered as supplementary tools.
To understand the essence of preoperative imaging, the pathophysiological mechanism of US formation should be explored, as the stricture is not limited to intraluminal pathology. The epithelial layer at the site of a stricture is much thicker than in healthy urethra due to changes within collagen fibers and elastin bundles densely packed around altered urethra [17]. This explains poor outcomes of repeated DVIU, resulting in scarring within the corpus spongiosum leading to spongiofibrosis.
Therefore, the role of imaging tool that would expose not only the exact length of the stricture, but also the extent of fibrosis, is undeniable. It is also confirmed by the treatment results—in patients with extensive spongiofibrosis the best are achieved by excision of the fibrotic fragment, followed by an end-to-end anastomosis of the two healthy ends. Yet, if the extent of fibrosis is less marked, urethroplasty with BMG may be the method of choice [18].
Undoubtedly, CUG/VCUG remains particularly valuable for initial diagnosis and planning of urethral reconstruction. Available, simple and repetitive, with satisfactory accuracy of diagnosing location and length of the stricture, as shown by this study, should still be the first choice. The value of urethroscopy cannot be underestimated either. However, with the painful and/or often impossible introduction of the tool in cases of significant or complete stricture, its application is limited and thus was not subjected to detailed evaluation in this paper.
As demonstrated, CUG/VCUG reveals tendency to underestimate the stricture length. This may be explained by its inability to assess the pathological periurethral tissue. To overcome this limitation, a combination of CUG/VCUG and SUG may be an optimal set of radiological tools for diagnosing patients with US, especially located in the penile urethra. It must be underlined that some significant outliers in the SUG measurement occurred in the studied group as mentioned previously. All of these errors were localized in the bulbar or membranous urethra, none in the penile urethra. This fully reflects the technical difficulties associated with performing SUG in the bulbar urethra and being almost impossible in the posterior urethra, despite proper patient positioning and high operator experience [19]. Transrectal sonographic approach may significantly improve the evaluation of posterior urethra, however, data on this technique and its accuracy is still limited [20]. Moreover, SUG is a subjective, operator-dependent procedure. Thus, despite its advantages, it may result in significant misdiagnosis of US, if excessive pressure of the probe is exerted.
Limitations in imaging of the posterior urethra were also reported by other authors in relation to the MRU examination. Sung et al. [11] assumed that proximal parts of the posterior urethra are rarely shown on MRU. However, based on our results, technical limitations of the MRU may be overcome by a strictly defined protocol of patient preparation with emphasis on patient positioning and accurate urethra distension. As such, MRU provides not only information about the length if the stricture, but also on surrounding tissues and pelvic anatomy, crucial in treatment planning.
Taking into account the accuracy of the radiological methods tested in this study as compared to the operative findings, MRU with average overestimation of 1.145 mm (MRU 1) and 0.727 mm (MRU 2) is the most accurate examination. Moreover, the almost perfect agreement between the radiologists’ assessment (MRU 1 vs MRU 2) indicates that MRU allows an objective assessment of the pathology regardless of an experienced investigator.
Yet, considering the higher cost and lower availability of MRU as compared with CUG/VCUG and SUG, its benefits will be the most valuable particularly in cases of post-traumatic US, multiple strictures (Fig. 3A, B) and strictures of the posterior urethra (Fig. 3D). MRU is also of particular value in patients after blunt force pelvic fracture who suffer from pelvic fracture urethral injury (PFUI) as both the direction and degree of prostatic displacement may be clearly depicted [21].
Moreover, 3D reconstructions and printed models allow the presentation of the pathology in an accessible form despite its complex nature. This noticeably valuable factor may be implemented in educating surgeons inexperienced in reconstructive urology. The ability to create such accurate models based on real urethral pathologies may also play a part in ongoing researches exploring tissue engineering in urethral reconstruction [22].
It is worth noting that CUG/VCUG, although less accurate in measuring the stricture length—with an average underestimation of 1.509 mm as compared with operative measure, also provides high accuracy, being less expensive and widely available. The disadvantage, however, is the lack of assessment of the pathology around the urethra and more frequent complaints reported by patients during intraurethral administration of the contrast.
In our study, SUG was the least accurate method with average overestimation of 2.127 mm as compared with the operative measure. Yet, in further analysis of the data—worse accuracy of SUG is a consequence of significant errors in measurements of strictures localized in the proximal and bulbar urethra, while in strictures in the distal and penile parts, no significant differences between MRU and SUG were revealed. Thus, should be routinely be considered in strictures located in the distal urethra and especially in the penile urethra being easily accessible to the examiner.
The authors of this study are aware of its limitations. First, this is a single-center study with a moderate number of patients. Second, intraoperative visual evaluation, despite being used by other authors, is not an ideal reference method for the assessment of spongiofibrosis [23]. Histopathological analysis of the excised urethra would be the most accurate reference, however, obtaining reliable specimens is a significant obstacle. The number of urethral specimens analyzed in this study prevented a statistically significant evaluation. Thus, a large multi-center clinical study taking into account the above limitations would undeniably let physicians gain valuable insights into urethral stricture disease.
Conclusions
Due to cost-effectiveness, availability and satisfactory accuracy, VCUG is still considered as a ‘gold standard’ in diagnosing urethral stricture disease despite its limitations.
Evaluation of the extent of spongiofibrosis should become an integral part of urethral stricture disease diagnostics as well as the length and location of strictures.
SUG and MRU should be taken into account in all cases when the diagnosis or the choice of optimal surgical method is uncertain. Combination of CUG/VCUG and SUG may be an optimal set of radiological tools for diagnosing patients with urethral strictures, especially located in the penile urethra.
MRU should be implemented particularly in cases of post-traumatic urethral strictures, multiple strictures and strictures located in the posterior urethra. MRU may also be successfully implemented in urethral reconstruction training centers due to the educational value of volumetric reconstructions and 3D printed models.
Availability of data and materials
Not applicable.
Code availability
Not applicable.
References
Lumen N et al (2009) Etiology of urethral stricture disease in the 21st century. J Urol 182:983. https://www.ncbi.nlm.nih.gov/pubmed/19616805)
Cooperberg MR, McAninch JW, Alsikafi NF, Elliott SP (2007) Urethral reconstruction for traumatic posterior urethral disruption: outcomes of a 25-year experience. J Urol 178:2006–2010. https://doi.org/10.1016/j.juro.2007.07.020.)
Cunnigham JH (1910) The diagnosis of stricture of the urethra by Roentgen rays. Trans Am Assoc Genitourin Surg 5:369–371
McCallum RW, Colapinto V (1979) The role of urethrography in urethral disease. Part I. Accurate radiological localisation of the membranous urethra and distal sphincter in normal male subjects. J Urol 122:607–611
Jordan G, Chapple C, Heyns C (2012) An international consultation on urethral strictures. Société Internationale d’Urologie (SIU); 2012:201–233. ISBN: 978–0–9877465–2–8
Rastogi R (2016) Can magnetic resonance urethrography (MRU) be a single-stop shop for male urethral stricture evaluation? JOJ Urol Nephrol 1:3–5. https://doi.org/10.19080/jojun.2016.1.555555
Meeks JJ, Erickson BA, Granieri MA et al (2009) Stricture recurrence after urethroplasty: a systematic review. J Urol 182(4):1266–1270
McAnnich JW, Laing FC, Jeffrey RB Jr (1988) Sonourethrography in the evaluation of urethral strictures: a preliminary report. J Urol 139(2):294–297. https://doi.org/10.1016/s0022-5347(17)42391-3 (PMID: 3276926)
Krukowski J, Kałużny A, Kłącz J, Matuszewski M (2018) Comparison between cystourethrography and sonourethrography in preoperative diagnostic management of patients with anterior urethral strictures. Med Ultrason 20(4):436–440. https://doi.org/10.11152/mu-1613
Chiou RK, Anderson JC, Tran T et al (1996) Evaluation of urethral strictures and associated abnormalities using high resolution and color Doppler ultrasound. Urology 47:102–107
Sung DJ, Kim YH, Cho SB et al (2006) Obliterative urethral stricture: MR urethrography versus conventional retrograde urethrography with voiding cystourethrography. Radiology 240:842
Contrast Media Safety Committee ESUR (2018) Guidelines on Contrast Media v10. CMSC. http://www.esur-cm.org/index.php
Dwivedi DK, Chatzinoff Y, Zhang Y, Yuan Q, Fulkerson M, Chopra R et al (2018) Development of a patient-specific tumor mold using magnetic resonance imaging and 3-dimensional printing technology for targeted tissue procurement and radiomics analysis of renal masses. Urology. https://doi.org/10.1016/j.urology.2017.08.056
Turner-Warwick R (1993) Principles of urethral reconstruction. In: Webster GD, Kirby R, King L et al (eds) Reconstructive urology. Blackwell Scientific Publications, Oxford, pp 609–642
Gupta N, Dubey D, Mandhani A, Srivastava A, Kapoor R, Kumar A (2006) Urethral stricture assessment: a prospective study evaluating urethral ultrasonography and conventional radiological studies. BJU Int 98:149–153
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174. https://doi.org/10.2307/2529310 ISSN 0006-341X JSTOR 2529310 (PMID 843571)
Baskin LS, Constantinescu SC, Howard PS (1993) Biochemical characterization and quantitation of the collagenous components of urethral stricture tissue. J Urol 150:426–647. https://doi.org/10.1016/s0022-5347(17)35572-6
Wood DN, Andrich DE, Greenwell TJ, Mundy AR (2006) Standing the test of time: the long-term results of urethroplasty. World J Urol 24:250–254. https://doi.org/10.1007/s00345-006-0057-3
Nash PA, McAninch JW, Bruce JE et al (1995) Sono-urethrography in the evaluation of anterior urethral strictures. J Urol 154(1):72–76
Sheehan JL, Naringrekar HV, Misiura AK et al (2021) The pre-operative and post-operative imaging appearances of urethral strictures and surgical techniques. Abdom Radiol. https://doi.org/10.1007/s00261-020-02879-8
Horiguchi A, Edo H, Soga S, Shinchi M, Masunaga A, Ito K, Asano T, Shinmoto H, Azuma R (2017) Pubo-urethral stump angle measured on preoperative MRI predicts urethroplasty type for pelvic fracture urethral injury repair. Urology. https://doi.org/10.1016/j.urology.2017.09.038
de Kemp V, de Graaf P, Fledderus JO, Ruud Bosch JLH, de Kort LMO (2015) Tissue engineering for human urethral reconstruction: systematic review of recent literature. PLoS ONE 10(2):e0118653. https://doi.org/10.1371/journal.pone.0118653
Tao W, Bai G, Fu G, Niu X, Wang H, Wang G (2019) MR urethrography versus X-ray urethrography compared with operative findings for the evaluation of urethral strictures. Int Urol Nephrol 51:1137–1143. https://doi.org/10.1007/s11255-019-02162-w
Funding
Publication of the article was supported by the project POWR.03.05.00-00-z082/18 co-financed by the European Union through the European Social Fund under the Operational Programme Knowledge Education Development 2014–2020.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
Age | Etiology | Stricture location (urethra) | Previous procedures | Surgery | Stricture length [mm] | Fibrosis (McAninch) | Fibrosis (Chiou) | IPSS | Q max | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CUG/VCUG | SUG | MRU1 | MRU2 | Intraoperative | Histopathology | SUG | MRU 1 | MRU 2 | Histopathology | SUG | MRU 1 | MRU 2 | Histpathology | At admission | > 3 m after operation | At admission | > 3 m after operation | ||||||
1 | 41 | Trauma (PFUI) | Bulbar | Newly diagnosed | End-to-end | 10 | 12 | 13 | 14 | 15 | 14 | S | S | S | S | 3 | 3 | 3 | 4 | 35 | 6 | 0 | 18.5 |
2 | 53 | Traumatic catheterisation | Bulbar | Newly diagnosed | End-to-end | 18 | 21 | 18 | 19 | 18 | 19 | S | S | MD | S | 3 | 2 | 2 | 3 | 14 | 1 | 5.9 | 23 |
3 | 69 | Post TURP | Bulbar | Newly diagnosed | End-to-end | 6 | 14 | 12 | 7 | 6 | 12 | S | S | S | MD | 3 | 3 | 3 | 1 | 23 | 3 | 8.1 | 15.6 |
4 | 41 | Trauma (PFUI) | Bulbar | Newly diagnosed | End-to-end | 12 | 25 | 16 | 17 | 15 | 15 | S | S | S | S | 3 | 3 | 3 | 3 | 32 | 4 | 3.3 | 30.3 |
5 | 21 | Hypospadias and LS | Penile | Newly diagnosed | BMG | 18 | 33 | 29 | 27 | 25 | – | S | S | S | – | 5 | 5 | 5 | – | 33 | 7 | 0 | 10 |
6 | 37 | Traumatic catheterisation | Penile | Newly diagnosed | BMG | 27 | 42 | 32 | 38 | 37 | – | S | MD | MD | – | 5 | 4 | 4 | – | 31 | 9 | 5 | 24 |
7 | 34 | Traumatic catheterisation | Bulbar | 2 × DVIU | End-to-end | 17 | 30 | 19 | 19 | 17 | – | S | S | MD | – | 4 | 2 | 2 | – | 28 | 2 | 0.5 | 45.5 |
8 | 57 | Post TURP | Penile | Newly diagnosed | BMG | 29 | 36 | 32 | 38 | 40 | – | S | S | S | – | 5 | 5 | 5 | – | 16 | 1 | 7.3 | 22 |
9 | 63 | Traumatic catheterisation | Bulbar | 10 × DVIU | BMG | 29 | 28 | 31 | 31 | 30 | – | M | M | M | – | 4 | 4 | 4 | – | 23 | 20 | 17.6 | 17.9 |
10 | 33 | Idiopathic | Bulbar | 6 × DVIU | BMG | 25 | 25 | 25 | 24 | 28 | – | S | S | S | – | 3 | 3 | 3 | – | 17 | 16 | 7.7 | 9 |
11 | 61 | Idiopathic | Bulbar | 18 × DVIU | End-to-end | 19 | 22 | 27 | 23 | 25 | 20 | S | S | S | S | 5 | 5 | 3 | 3 | 26 | 17 | 0 | 4 |
12 | 67 | Traumatic catheterisation | Penile | Newly diagnosed | Orandi flap | 21 | 30 | 29 | 28 | 30 | – | S | S | S | – | 5 | 5 | 5 | – | 25 | 30 | 0.5 | 8.3 |
13 | 51 | Trauma (penile fracture) | Penile | Newly diagnosed | BMG | 5 | 20 | 3 | 3 | 5 | – | S | S | S | – | 4 | 3 | 3 | – | 32 | 4 | 7.7 | 28.7 |
14 | 67 | Post TURP | Bulbar | DVIU | End-to-end | 12 | 33 | 23 | 21 | 19 | 20 | S | S | S | S | 3 | 3 | 3 | 3 | 23 | 11 | 4.3 | 20.7 |
15 | 54 | Trauma (PFUI) | Bulbar | 1 × DVIU | Not performed | NS | NS | NS | NS | – | – | – | – | – | – | – | – | – | – | 35 | 30 | 12 | 12.5 |
16 | 82 | Post TURP | Bulbar | 4 × DVIU | End-to-end | 36 | 55 | 38 | 34 | 35 | 32 | S | S | MD | S | 5 | 5 | 5 | 5 | 33 | 4 | 3 | 18 |
17 | 72 | Post TURP | Penile | 1 × DVIU | BMG | 14 | 25 | 23 | 28 | 30 | – | MD | MD | MD | – | 3 | 3 | 4 | – | 32 | 19 | 5.1 | 24 |
18 | 87 | Traumatic catheterisation | Bulbar | 2 × DVIU | End-to-end | 10 | 21 | 15 | 10 | 12 | – | S | MD | MD | – | 3 | 2 | 2 | – | 27 | 20 | 11 | 12 |
19 | 64 | Idiopathic | Bulbar | 1 × DVIU | End-to-end | 10 | 16 | 11 | 11 | 10 | – | S | S | S | – | 3 | 2 | 2 | – | 13 | 3 | 16.5 | 21 |
20 | 62 | Trauma (straddle injury) | Bulbar and membranous | 1 × DVIU | End-to-end | 10 | 12 | 11 | 12 | 15 | 12 | S | MD | MD | S | 3 | 2 | 2 | 2 | 12 | 7 | 0 | 16 |
21 | 67 | Post TURP | Penile and bulbar | 5 × DVIU | BMG | 9 | 22 | 9 | 10 | 10 | – | MD | M | M | – | 2 | 2 | 2 | – | 30 | 1 | 8.5 | 10.3 |
22 | 51 | Trauma (straddle injury) | Bulbar | 2 × DVIU | End-to-end | 28 | 23 | 34 | 37 | 35 | – | S | S | S | – | 5 | 5 | 5 | – | 16 | 4 | 0 | 10 |
23 | 74 | Traumatic catheterisation | Bulbar | 3 × DVIU | BMG | 12 | 27 | 20 | 21 | 20 | – | MD | MD | MD | – | 2 | 2 | 2 | – | 29 | 4 | 5 | 17 |
24 | 39 | Idiopathic | Bulbar | 5 × DVIU | BMG | 18 | 30 | 18 | 18 | 18 | – | MD | MD | MD | – | 2 | 2 | 2 | – | 21 | 7 | 9 | 28.7 |
25 | 71 | Trauma (PFUI) | Bulbar | 13 × DVIU | End-to-end | 25 | 20 | 28 | 27 | 25 | – | S | S | MD | – | 5 | 5 | 5 | – | 21 | 9 | 6 | 12 |
26 | 46 | Trauma (PFUI) + TURP | Bulbar | 4 × DVIU | Cystostomy | 65 | 27 | 65 | 66 | – | – | S | S | S | – | 5 | 5 | 5 | – | 22 | 35 | 0 | – |
27 | 56 | Trauma (PFUI) | Bulbar and membranous | 1 × UP | End-to-end | 21 | 20 | 21 | 20.5 | 20 | – | S | S | S | – | 3 | 3 | 3 | – | 26 | 2 | 11 | 16 |
28 | 54 | Trauma (PFUI) | Bulbar | 2 × UP | DVIU | 4 | 5 | 5 | 5 | 4 | – | S | S | S | – | 2 | 2 | 2 | – | 35 | 4 | 17 | 21 |
29 | 68 | RT | Bulbar | 1 × DVIU | BMG | 25 | 25 | 25 | 25 | 25 | – | S | S | S | – | 3 | 3 | 5 | – | 31 | 30 | 4 | 15.1 |
30 | 38 | Trauma (straddle injury) | Penile and bulbar | 3 × DVIU + circumcision | BMG | 80 | 80 | 81 | 65 | 65 | – | MD | MD | MD | – | 5 | 5 | 4 | – | 22 | 7 | 11.9 | 25.6 |
31 | 34 | Trauma (PFUI) | Bulbar and membranous | 3 × DVIU | End-to-end | 11 | 12 | 12 | 14 | 15 | – | S | S | S | – | 3 | 3 | 3 | – | 16 | 9 | 0 | 55 |
32 | 73 | Post prostatectomy + RT + AMS | Bulbar | AMS | End-to-end | 17 | 18 | 17 | 19.5 | 18 | – | S | S | S | – | 3 | 3 | 3 | – | 23 | 35 | 0 | 9 |
33 | 65 | Post URSL | Bulbar and membranous | 4 × DVIU | BMG | 30 | 22 | 24 | 24 | 25 | – | MD | MD | MD | – | 3 | 3 | 3 | – | 32 | 1 | 9.1 | 18.2 |
34 | 63 | Post TURP | Bulbar | 2 × DVIU | BMG | 39 | 54 | 47 | 48 | 45 | – | S | S | MD | – | 5 | 5 | 3 | – | 16 | 11 | 4.4 | 21 |
35 | 43 | Traumatic catheterisation | Bulbar | 2 × DVIU | BMG | 30 | 28 | 30 | 33 | 30 | – | S | S | S | – | 5 | 5 | 5 | – | 30 | 10 | 11.7 | 35.1 |
36 | 75 | Post TURP | Membranous and prostatic | DVIU + UP | DVIU | 15 | 12 | 10 | 10 | 10 | – | S | S | S | – | 3 | 3 | 3 | – | 23 | 3 | 4.1 | 14 |
37 | 68 | Post TURP | Membranous | 2 × DVIU + TURP | End-to-end | 4 | 7 | 5 | 5.5 | 5 | – | S | S | S | S | 3 | 3 | 3 | 3 | 17 | 3 | 3.1 | 13.2 |
38 | 78 | Post TURP | Membranous | 3 × DVIU + TURP | BMG | 25 | 24 | 26 | 24 | 22 | – | MD | MD | MD | – | 4 | 4 | 2 | – | 26 | 1 | 4.1 | 14.5 |
39 | 64 | Post TURP | Penile and bulbar | 3 × DVIU + TURP | BMG | 36 | 37 | 36 | 35 | 35 | – | S | S | S | – | 5 | 5 | 5 | – | 25 | 19 | 2.5 | 11 |
40 | 71 | Post prostate brachytherapy | Membranous | 2 × DVIU | Cystostomy | 22 | 20 | 20 | 20 | – | – | S | S | S | – | 3 | 3 | 3 | – | 18 | 35 | 0 | 0 |
41 | 74 | Post TURBT and TURP | Penile | Meatotomy | Johansen | 24 | 24 | 24 | 24 | 22 | – | S | S | S | – | 3 | 3 | 3 | – | 31 | 2 | 7 | 21 |
42 | 67 | Idiopathic | Bulbar | 10 × DVIU | BMG | 28 | 29 | 28 | 23 | 25 | – | S | S | S | – | 5 | 5 | 3 | – | 22 | 2 | 4.5 | 14 |
43 | 70 | Post TURP | Bulbar | TURP | End-to-end | 14 | 24 | 22 | 23 | 22 | – | S | S | S | – | 3 | 3 | 3 | – | 32 | 4 | 4 | 21 |
44 | 48 | Trauma | Bulbar | TURP | End-to-end | 16 | 23 | 22 | 22.5 | 25 | – | S | S | S | – | 3 | 3 | 3 | – | 30 | 4 | 3.2 | 11 |
45 | 25 | Trauma (straddle injury) | Bulbar | Newly diagnosed | BMG | 60 | 72 | 71 | 71 | 70 | – | MD | MD | MD | – | 5 | 4 | 4 | – | 35 | 2 | 0 | 12 |
46 | 36 | Trauma (PFUI) | Bulbar | 1 × DVIU | End-to-end | 4 | 6 | 4 | 5.5 | 5 | – | M | M | M | – | 3 | 2 | 2 | – | 33 | 6 | 0 | 8 |
47 | 58 | Trauma (straddle injury) | Penile and bulbar + urethral fistula | 3 × UP | BMG | 11 | 15 | 64 | 64 | 60 | – | MD | MD | MD | – | 4 | 4 | 4 | – | 18 | 21 | 2.6 | 16 |
48 | 64 | Post TURP | Bulbar | 3 × DVIU | BMG | 41 | 58 | 29 | 23 | 25 | – | MD | MD | M | – | 3 | 4 | 2 | – | 23 | 2 | 10 | 16.7 |
r-BMG | 6 | 3 | 4 | 6 | 3 | – | S | S | S | – | 4 | 3 | 3 | – | 32 | 4 | 7.7 | 18 | |||||
49 | 45 | Traumatic catheterisation | Bulbar | 7 × DVIU | Johansen | 20 | 11 | 20 | 22 | 15 | – | MD | M | M | – | 2 | 1 | 1 | – | 30 | 12 | 0 | 13.5 |
r-end-to-end | 9 | 6 | 7 | 8 | 3 | 2 | MD | MD | MD | MD | 3 | 4 | 4 | 2 | 16 | 4 | 7.5 | 17 | |||||
50 | 53 | Post URSL | Bulbar | 20 × DVIU | BMG | 23 | 22 | 25 | 21 | 20 | – | MD | M | M | – | 4 | 4 | 2 | – | 21 | 18 | 7 | 22 |
Penile | r-BMG | 26 | 25 | 35 | 30 | 30 | – | S | MD | MD | – | 5 | 5 | 5 | – | 8 | 3 | 9 | 24 | ||||
51 | 70 | Post TURP | Penile | 2 × DVIU | BMG | 23 | 26 | 23 | 22 | 20 | – | S | S | S | – | 3 | 3 | 3 | – | 1 | 1 | 8 | 11 |
Bulbar | r-end-to-end | 25 | 28 | 25 | 24 | 23 | – | S | S | S | – | 4 | 4 | 3 | – | 2 | 9 | 13 | |||||
52 | 79 | Post TURP | Bulbar | 4 × DVIU | DVIU | 5 | 8 | 5 | 5 | 4 | – | S | S | S | – | 3 | 3 | 3 | – | 14 | 12 | 8.4 | 9.1 |
Bulbar and membranous | r-end-to-end | 32 | 30 | 37 | 36 | 30 | – | MD | MD | MD | – | 5 | 5 | 5 | – | 23 | 20 | 6.4 | 11 | ||||
53 | 64 | Post TURP | Membranous | 2 × DVIU + 2 × TURP | End-to-end | 27 | 27 | 29 | 28 | 28 | – | S | S | MD | – | 5 | 5 | 5 | – | 32 | 3 | 6 | 12.5 |
Bulbar | r-end-to-end | 13 | 12 | 12.5 | 12 | 10 | – | MD | MD | MD | – | 2 | 2 | 2 | – | 33 | 6 | 9 | 11 | ||||
54 | 46 | Trauma (PFUI) | Penile and bulbar | 2 × DVIU | End-to-end | 12 | 12 | 10 | 10 | 12 | – | S | S | S | – | 3 | 3 | 3 | – | 32 | 11 | 0 | 9 |
Penile | r-BMG | 70 | 55 | 53 | 54 | 50 | – | MD | MD | MD | – | 4 | 4 | 4 | – | 8 | 20 | 0 | 11.5 | ||||
55 | 68 | TURP | Penile | 2 × DVIU + TURP | BMG | 2 | 6 | 5 | 6.5 | 7 | – | S | S | S | – | 3 | 3 | 3 | – | 8 | 21 | 0 | 11.5 |
r-BMG | 12 | 4 | 3 | 4 | 5 | – | S | S | S | – | 3 | 3 | 3 | – | 32 | 27 | 3 | 11 |
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mikolaj, F., Karolina, M., Oliwia, K. et al. Retrograde urethrography, sonouretrography and magnetic resonance urethrography in evaluation of male urethral strictures. Should the novel methods become the new standard in radiological diagnosis of urethral stricture disease?. Int Urol Nephrol 53, 2423–2435 (2021). https://doi.org/10.1007/s11255-021-02994-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-021-02994-5